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Background: Staphylococcus epidermidis is the major bacterial species found in biofilm-related infections on
indwelling medical devices. Microbial biofilms are communities of bacteria adhered to a surface and surrounded by
an extracellular polymeric matrix. Biofilms have been associated with increased antibiotic tolerance to the immune
system. This increased resistance to conventional antibiotic therapy has lead to the search for new antimicrobial
therapeutical agents. Farnesol, a quorum-sensing molecule in Candida albicans, has been described as impairing
growth of several different microorganisms and we have previously shown its potential as an adjuvant in
antimicrobial therapy against S. epidermidis. However, its mechanism of action in S. epidermidis is not fully known. In
this work we better elucidate the role of farnesol against S: epidermidis biofilms using confocal laser scanning
microscopy (CLSM).
Findings: 24 h biofilms were exposed to farnesol, vancomycin or rifampicin and were analysed by CLSM, after
stained with a Live/Dead stain, a known indicator of cell viability, related with cell membrane integrity. Biofilms
were also disrupted by sonication and viable and cultivable cells were quantified by colony forming units (CFU)
plating. Farnesol showed a similar effect as vancomycin, both causing little reduction of cell viability but at the
same time inducing significant changes in the biofilm structure. On the other hand, rifampicin showed a distinct
action in S. epidermidis biofilms, by killing a significant proportion of biofilm bacteria.
Conclusions: While farnesol is not very efficient at killing biofilm bacteria, it damages cell membrane, as
determined by the live/dead staining, in a similar way as vancomycin. Furthermore, farnesol might induce biofilm
detachment, as determined by the reduced biofilm biomass, which can partially explain the previous findings
regarding its role as a possible chemotherapy adjuvant.Findings
Background
Staphylococcus epidermidis, a normal inhabitant of
human skin and mucosa, has recently emerged as a lead-
ing cause of biofilm-related infections, particularly, in
patients with indwelling medical devices [1,2] due to its
ability to adhere to abiotic surfaces and to form biofilms
[2,3]. Biofilms are often defined as three-dimensional
communities of microorganisms that are attached to a
surface and encased in an extracellular matrix composed
mainly of polysaccharides, proteins and extracellular* Correspondence: nunocerca@ceb.uminho.pt
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reproduction in any medium, provided the orDNA [4,5]. The major virulence factor of S. epidermidis
is biofilm formation [6] and cells in biofilms are nor-
mally more tolerant to antibiotics than planktonic cells
[7-9], making drug resistance in a S. epidermidis biofilm-
related infection a serious problem, especially in nosoco-
mial infections [10]. S. epidermidis are also inherently
resistant to host defense mechanisms [11,12]. The
increased resistance to conventional antibiotic therapy
led to the search for new therapeutical agents.
Despite concerted efforts to treat biofilm-related infec-
tions with antibiotic therapy, the physical removal of the
infected medical device is often necessary [13], which
carries an additional economic and health cost. There-
fore, novel strategies are necessary to combat biofilm-
related infections to improve clinical outcomes.td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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quorum-sensing molecule described in eukaryotes [14]
and produced by most Candida species [15]. Farnesol
has been shown to have antimicrobial activity in many
species [16], including the coagulase positive Staphylo-
coccus aureus [17,18] and the coagulase negative Staphy-
loccous epidermidis [19]. Recently, we showed that
farnesol could act as an adjuvant against S. epidermidis
infections, when combined with common antibiotics
such as vancomycin, tetracycline and rifampicin. How-
ever, this effect was more proeminent in planktonic cells
and was significantly reduced in biofilms [20]. Neverthe-
less, Pammi et al. had shown that combinations of farne-
sol with other antibiotics were also effective in reducing
S. epidermidis biofilm biomass [21].
Despite the promising role of farnesol as an adjuvant
in antimicrobial activity against S. epidermidis, little is
known regarding its mechanism of action. We have pre-
viously shown that the biofilm matrix composition and
distribution of S. epidermidis biofilms was affected by
farnesol [22]. In this study we present a more in-depth
analysis of biofilm structure, viability and biomass
changes when in contact with farnesol, and compare it
with biofilms exposed to vancomycin or rifampicin.
Material and methods
Bacterial strains and growth conditions
The biofilm-producing strain used in this study, S. epi-
dermidis 9142,was previously described [23]. This strain
was originally isolated from blood cultures from an
infected central venous catheter by Mack et al. [24],
Strains were grown as previously described, in Tryptic
Soy Broth (TSB) and Tryptic Soy Agar (TSA) (Oxoid,
Cambridge, UK) [25]. Briefly the strain was inoculated
into 15 mL of TSB from TSA plates not older than
2 days and grown for 18 (± 2) h at 37°C in an orbital
shaker at 130 rpm. Cells were harvested by centrifuga-
tion (for 10 min at 9500 × g and 4°C), and resuspended
in TSB supplemented with 0.25% glucose (TSBG) (Fisher
Scientific, Waltham, MA, US) adjusted to an optical
density (640 nm) equivalent to 1 × 109 cells mL-1 and
then used in the subsequent assays.
Biofilm challenge with farnesol, vancomycin or rifampicin
Biofilm challenge was done as described before [26],
with some modifications. Briefly, biofilms were formed
during 24 h at 37°C and 120 rpm on 96 (for killing
assays) or 6-well tissue culture (for confocal analysis)
plates by dispensing 4 mL of a 1 × 109 cells mL-1 cell
suspension in TSBG. Then, the growth medium was
removed and replaced with fresh TSBG supplemented
with either 300 μM of farnesol (Sigma, St Louis, MO,
US) [19], or the antibiotics at the respective peak serum
concentration (vancomycin: 40 mg/L and rifampicin:10 mg/L) (Sigma, St Louis, MO, US) [9]. Biofilms were
exposed to the respective antimicrobial agents for 2, 4,
6, 8 or 24 h. After exposure, biofilms were sonicated for
10 seconds at 10 W (Ultrasonic Processor, Cole-Parmer,
USA). This procedure did not reduced cell viability, as
showed before [9]. The cell suspension was washed
twice to prevent antibiotic carry over and resuspended
in 0.9% NaCl. Viable bacteria were determined by stand-
ard colony-forming-units (CFU) plating in TSA plates.
This experiment was repeated three times with
duplicates.
Confocal scanning laser microscopy (CLSM) analysis of
the biofilms
CSLM was performed as described before [22]. Briefly,
24 h after the biofilms were exposed to farnesol, vanco-
mycin or rifampicin, they were washed twice with 0.9%
NaCl. Biofilm cell viability was determined with live/
dead staining (Molecular Probes, USA) following the
manufacturer´s instructions. A negative control was
used to determine the baseline threshold for dead cells,
by killing the biofilm with 96% ethanol for 4 h. The
plates were incubated for 20 min at room temperature
in the dark. After staining, the biofilms were gently
rinsed with 0.9% NaCl. The biofilm images were
acquired in an OlympusTM FluoView FV1000 (Olympus,
Lisboa, Portugal) confocal scanning laser microscope.
Biofilms were observed using a 60x water-immersion ob-
jective (60x/1.2 W). For each condition, three independ-
ent biofilms were used. Images were acquired with 512 x
512 resolutions in at least four different regions of each
surface analyzed. For biofilm maximum thickness deter-
mination, at least twenty different regions per surface
were analyzed, by determining the the top and bottom
layer of the biofilm, and calculating the maximum thick-
ness of each region.
Statistical analysis
Quantitative assays were compared using unpaired t-test
or one-way analysis of variance (ANOVA) by applying
Levene’s test of homogeneity of variances and the Tukey
multiple comparisons test. All tests were performed with
a confidence level of 95%.
Results and discussion
Antibiotic resistance is a serious problem in S. epidermidis
since many clinical isolates of this organism are resistant
up to eight different antibiotics [10]. Farnesol is one prom-
ising candidate to be used as an adjuvant in antimicrobial
chemotherapy against biofilms. Some studies have indi-
cated a possible interaction of farnesol with cell mem-
branes of S. aureus, resulting in a reduced cell membrane
integrity [18]. We have recently shown that farnesol
increased cell death by the action of tetracycline or
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the cell wall [22]. The same was true in combination with
N-acetylcysteine [27]. However, the exact mechanism of
farnesol action in S. epidermidis is not fully known. A re-
cent study of Zhu et al. [28] revealed that farnesol induced
Candida albicans apoptosis by conjugating with intracel-
lular glutathione, inducing a strong oxidative stress and
eventual cell death. However, as C. albicans biology is fun-
damentally different from S. epidermidis, it is not possible
to infer a similar role of farnesol in S. epidermidis
biofilms.
Based on our previous findings [19,20,22,27], we
selected two antibiotics with distinct mechanisms of ac-
tion: vancomycin, that inhibits the cell wall synthesis
and shows low activity against S. epidermidis biofilms,
and rifampicin, a RNA synthesis inhibitor, that shows
high activity against S. epidermidis biofilms and com-
pared their effects with farnesol action on biofilm struc-
ture and cell viability. Figure 1 shows a time-course
study on viable cells after exposure to the three anti-
microbial agents. As expected, vancomycin was not very
effective in killing biofilm bacteria. In fact, as compared
with the control, the only significant difference found
was at 24 h of exposure. On the other hand, rifampicin
was able to kill more than 1 log of bacteria in the first
two hours of exposure, and more than 2.5 log after 8 h.
Farnesol showed similar results as vancomycin in all
time periods studied.
CLSM has been widely used to study biofilm structure,
composition and metabolism in several different microor-
ganisms [29-31]. One of the big advantages of CLSM is
that it allows in-depth analysis of biological structures,Figure 1 Effect of farnesol, vancomycin, and rifampicin on viability of
different as compared with the control, at the respective time-point (p < 0.without killing or damaging the biological structure [32].
Live/dead staining has been used as indicator of cell viabil-
ity, as determined by the integrity of the cell wall mem-
brane in many bacterial populations, including biofilms
[19,33]. When we analyzed the biofilm structure and via-
bility by CLSM an interesting result was found: despite
the fact that vancomycin and farnesol were not able to ef-
fectively kill biofilm bacteria, biofilm biomass was strongly
reduced, as can be seen qualitatively in Figure 2 or quanti-
tatively in Figure 3. In fact, the biofilm maximum depth,
an indirect measure of the amount of biofilm biomass was
equally reduced when treated with any of the three differ-
ent antimicrobial compounds used (Figure 3). For better
comparison of the antimicrobials action, regions of bio-
films with similar deepness were chosen (Figure 2C, D, E).
More images can be found in supplementary information
(Additional file 1, Additional file 2, Additional file 3 and
Additional file 4). It is well known that bacterial biofilms
are heterogeneous communities, regarding both the three
dimensional structure but also the physiology of in vitro
biofilm bacteria [4]. It was recently described that S. epi-
dermidis biofilms have a variable sub-population of cells
presenting a partially damaged cell membrane. This sub-
population was able to incorporate propidium iodide at
low levels, but were still viable bacteria [34]. In the present
study, biofilms treated with vancomycin or farnesol
showed clusters of live (green) and death bacteria (red)
but also a sub-population of bacteria with somewhat
damaged cell membrane (yellow). Despite the fact that
biofilms exposed to vancomycin or farnesol had smaller
amounts of biomass, the typical S. epidermidis biofilm
high density cell clusters were still detected [35-38]. OnS. epidermidis biofilm cells versus time of treatment.* statistically
05).
Figure 2 Effect of farnesol and antibiotics on biofilm structure and viability. (A) Biofilm without antimicrobial agent; (B) Negative control
for live/dead staining, treated with 96% ethanol for 4 h; (C) Biofilm exposed to 300 μM farnesol for 24 h; (D) Biofilm exposed to 40 mg/L of
vancomycin for 24 h; (E) Biofilm exposed to 10 mg/L of rifampicin for 24 h.
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Figure 3 Effect of farnesol and antibiotics on biofilms maximum depth. * statistically different as compared with the control (p < 0.05).
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sented regions of live or somewhat damage cell clusters.
While live and viable bacteria were mainly dispersed in
small microcolonies, the few cluster found were of dead
bacteria (Figure 2E).
Since it is well known that biofilm cells are metabol-
ically less active than planktonic ones [39] and some
cells are in a dormant state [40], antibiotics that re-
quire active cell division, such as vancomycin, are
highly hindered in such conditions. Nevertheless, the
reduced biomass present suggested that both agents
targeting the cell wall were able to, somehow, induce
cell detachment. While S. epidermidis biofilms have
been proposed to partially detach fragments of the
biofilm [6] in order to potentially colonize other
regions of the host, cell detachment is not yet fully
understood, however some genetic regulation might be
involved [41]. Recently Kaneko et al. showed that far-
nesol interfered with the S. aureus mevalonate path-
way, which is related with cell membrane maintenance
and protein anchoring, among other important cell
functions [42]. S. aureus biofilm production and me-
tabolism is similar to S. epidermidis [43]. It has been
shown before that the lack of proper protein anchor-
ing results in reduced biofilm formation in S. aureus
and S. epidermidis, related with regulation of poly-N-
acetyl-β-(1–6)-glucosamine deacetylation [11,44].
Conclusions
Treatment of S. epidermidis biofilms with farnesol
and vancomycin did not significantly decrease cell
viability. However, they both appeared to reduce the
biomass in these biofilms. Our previous reports
regarding the role of farnesol as an adjuvant inantimicrobial chemotherapy can now be better
explained, since released cells from the biofilms
would potentially be more prone to antibiotic attack,
taking in consideration that no diffusion barrier
would be present in such cases [45]. Kaneko et al.
[42] results and ours further provide more evidence
that farnesol mechanism of action in S. epidermidis is
related with the cell wall membrane integrity. We are
currently exploring the role of farnesol in S. epidermi-
dis cell membrane integrity as well as its impact on
biofilm physiology.Additional files
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